Literature DB >> 16180082

Calpain-1-sensitive myofibrillar proteins of the human myocardium.

Judit Barta1, Attila Tóth, István Edes, Miklós Vaszily, Julius Gy Papp, András Varró, Zoltán Papp.   

Abstract

Calpain-1 is a ubiquitous intracellular Ca2+-activated protease, which has been implicated in the pathogenesis of reversible myocardial depression (i.e. myocardial stunning) that follows ischemia and reperfusion via myofibrillar protein degradation. However, the target proteins of this degradative process in the human myocardium have not yet been identified. In order to compare the levels of Calpain-1 susceptibility within a set of human myofibrillar proteins (titin, alpha-fodrin, desmin, troponin T (cTnT), troponin I (cTnI) and alpha-actinin), crude left ventricular tissue homogenates were incubated for 0.5, 15, 30, 60 or 120 min in the presence of Calpain-1 (1 U or 5 U). Differences in the kinetics and extents of protein degradation were subsequently evaluated by using silver-stained SDS-polyacrylamide gels and Western immunoblot analyses. These assays revealed myofibrillar proteins with high (titin and alpha-fodrin), moderate (desmin and cTnT), or low (cTnI and alpha-actinin) relative Calpain-1 susceptibilities. The level of phosphorylation of cTnI did not explain its relatively low Calpain-1 susceptibility. Moreover, the molecular mass distributions of the truncated alpha-fodrin, desmin and cTnI fragments resulting from Ca2+-dependent autoproteolysis exhibited marked similarities with those of their Calpain-1-clipped products. These in vitro results shed light on a number of structural (titin, alpha-fodrin, desmin and alpha-actinin) and regulatory (cTnT and cTnI) proteins within the contractile apparatus as potential targets of Calpain-1. Their degradation may contribute to the development of postischemic stunning in the human myocardium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180082     DOI: 10.1007/s11010-005-1370-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  Biochemical mechanism(s) of stunning in conscious dogs.

Authors:  H Lüss; A Meissner; N Rolf; H Van Aken; P Bokník; U Kirchhefer; J Knapp; S Läer; B Linck; I Lüss; F U Müller; J Neumann; W Schmitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

2.  Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts.

Authors:  M V Westfall; R J Solaro
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

3.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium.

Authors:  W D Gao; D Atar; Y Liu; N G Perez; A M Murphy; E Marban
Journal:  Circ Res       Date:  1997-03       Impact factor: 17.367

4.  Transgenic mouse model of stunned myocardium.

Authors:  A M Murphy; H Kögler; D Georgakopoulos; J L McDonough; D A Kass; J E Van Eyk; E Marbán
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

5.  Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation.

Authors:  F Di Lisa; R De Tullio; F Salamino; R Barbato; E Melloni; N Siliprandi; S Schiaffino; S Pontremoli
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

6.  Studies of the alpha-actinin/actin interaction in the Z-disk by using calpain.

Authors:  D E Goll; W R Dayton; I Singh; R M Robson
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

7.  Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure.

Authors:  A van der Laarse
Journal:  Cardiovasc Res       Date:  2002-10       Impact factor: 10.787

8.  Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.

Authors:  Judit Barta; Attila Tóth; Kornelia Jaquet; Alexander Redlich; István Edes; Zoltán Papp
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

9.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

10.  Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury.

Authors:  J L McDonough; D K Arrell; J E Van Eyk
Journal:  Circ Res       Date:  1999 Jan 8-22       Impact factor: 17.367

View more
  15 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.

Authors:  Sarah M Schumacher-Bass; Eileen D Vesely; Lian Zhang; Katherine E Ryland; Dyke P McEwen; Priscilla J Chan; Chad R Frasier; Jeremy C McIntyre; Robin M Shaw; Jeffrey R Martens
Journal:  Circ Res       Date:  2014-02-07       Impact factor: 17.367

3.  Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains.

Authors:  Min-Young Kang; Yan Zhang; Scot J Matkovich; Abhinav Diwan; Athar H Chishti; Gerald W Dorn
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

4.  Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness.

Authors:  G S Supinski; W Wang; L A Callahan
Journal:  J Appl Physiol (1985)       Date:  2009-08-06

5.  Calpain inhibition attenuates right ventricular contractile dysfunction after acute pressure overload.

Authors:  Clifford R Greyson; Gregory G Schwartz; Li Lu; Shuyu Ye; Steve Helmke; Ya Xu; Hasan Ahmad
Journal:  J Mol Cell Cardiol       Date:  2007-10-23       Impact factor: 5.000

Review 6.  Atrial Calpains: Mediators of Atrialmyopathies in Atrial Fibrillation.

Authors:  Alicja Bukowska; Uwe Lendeckel; Andreas Goette
Journal:  J Atr Fibrillation       Date:  2014-04-30

7.  Calpain-dependent cleavage of junctophilin-2 and T-tubule remodeling in a mouse model of reversible heart failure.

Authors:  Chia-Yen C Wu; Biyi Chen; Ya-Ping Jiang; Zhiheng Jia; Dwight W Martin; Shengnan Liu; Emilia Entcheva; Long-Sheng Song; Richard Z Lin
Journal:  J Am Heart Assoc       Date:  2014-06-23       Impact factor: 5.501

Review 8.  Emerging importance of oxidative stress in regulating striated muscle elasticity.

Authors:  Lisa Beckendorf; Wolfgang A Linke
Journal:  J Muscle Res Cell Motil       Date:  2014-11-06       Impact factor: 2.698

9.  Troponin I phosphorylation in human myocardium in health and disease.

Authors:  P J M Wijnker; A M Murphy; G J M Stienen; J van der Velden
Journal:  Neth Heart J       Date:  2014-10       Impact factor: 2.380

10.  Bromine inhalation mimics ischemia-reperfusion cardiomyocyte injury and calpain activation in rats.

Authors:  Shama Ahmad; Juan Xavier Masjoan Juncos; Aftab Ahmad; Ahmed Zaky; Chih-Chang Wei; Wayne E Bradley; Iram Zafar; Pamela Powell; Nithya Mariappan; Nilam Vetal; William E Louch; David A Ford; Stephen F Doran; Sadis Matalon; Louis J Dell'Italia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.